Showcases Stock ranks Forex

Seelos Therapeutics Inc (SEEL)
0.9002  -0.1 (-9.97%) 08-08 16:00
Open: 0.97 Pre. Close: 0.9999
High: 1.04 Low: 0.9002
Volume: 1,218,314 Market Cap: 96M
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 1.041 - 1.046 1.046 - 1.049
Low: 0.889 - 0.895 0.895 - 0.899
Close: 0.891 - 0.9 0.9 - 0.906
Stock Technical Analysis
Target: Six months: 1.21
One year: 1.42
Support: Support1: 0.85
Support2: 0.74
Resistance: Resistance1: 1.04
Resistance2: 1.21
Pivot: 0.91
Moving Averages: MA(5): 0.93
MA(20): 0.91
MA(100): 0.75
MA(250): 1.33
MACD: MACD(12,26): 0.03
Signal(12,26,9): 0.04
%K %D: %K(14,3): 60.35
%D(3): 53.45
RSI: RSI(14): 52.78
52-Week: High: 2.79
Low: 0.48
Change(%): -55.2
Average Vol(K): 3-Month: 1193
10-Days: 542
Price, MAs and Bollinger Bands
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.

[ SEEL ] has closed above bottom band by 46.4%. Bollinger Bands are 8.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Mon, 18 Jul 2022
2022-07-18 | NDAQ:SEEL | Press Release | Seelos Therapeutics Inc. - Stockhouse

Thu, 09 Jun 2022
Seelos Therapeutics (SEEL) Stock Price: Why It Increased 3.68% Today - Pulse 2.0

Wed, 18 May 2022
Seelos Therapeutics Receives a Notice of Allowance in the U.S. for an Additional Patent for SLS-007 - PR Newswire

Thu, 12 May 2022
Seelos Therapeutics to Participate in the 2022 Jefferies Global Healthcare Conference - Yahoo Finance

Fri, 22 Apr 2022
Seelos Therapeutics to Participate in the B. Riley Securities' Virtual Neuro and Ophthalmology Conference - PR Newswire

Mon, 11 Apr 2022
Seelos Therapeutics Announces Amendment of SLS-002 Agreement to Repurchase the Remaining Royalties Payable to Phoenixus AG for SLS-002 (Intranasal Racemic Ketamine Program), All Future Success and Commercial Based Milestones and the Cha - Yahoo Finance

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 106.09
Shares Float (M) 101.32
% Held by Insiders 4.83
% Held by Institutions 41.21
Shares Short (K) 6580
Shares Short Prior Month (K) 9440
Stock Financials
EPS -0.609
Book Value (p.s.) 0.250
Profit Margin
Operating Margin
Return on Assets (ttm) -64.3
Return on Equity (ttm) -134.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -66.29
Levered Free Cash Flow (M) -46.35
Stock Valuation
PE Ratio -1.48
PEG Ratio
Price to Book value 3.60
Price to Sales
Price to Cash Flow -1.44
Stock Dividends
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android